Pharmaceutical company Gilead Sciences on Wednesday reported potentially encouraging results from a trial for a drug that’s being tested as a treatment for the coronavirus. Gilead said that the antiviral drug Remdesivir produced “similar improvement” in patients over a 10-day treatment plan compared with a five-day treatment plan – and that it recorded “no new safety” issues among hospitalized patients who “well-tolerated” the treatment in the study. “The study demonstrates the potential for some patients to be treated with a 5-day regimen, which could significantly expand the number of patients…
Read MoreBREAK THROUGH: US DRUG MAKER GILEAD SCIENCES REPORTS POSITIVE DRUG RESULTS FOR REMDESIVIR AS CORONAVIRUS TREATMENT
